Nevanimibe
Nevanimibe Uses, Dosage, Side Effects, Food Interaction and all others data.
Nevanimibe is under investigation in clinical trial NCT03053271 (A Study of ATR-101 for the Treatment of Endogenous Cushing's Syndrome).
| Trade Name | Nevanimibe |
| Generic | Nevanimibe |
| Nevanimibe Other Names | Atr-101 free base, Nevanimibe |
| Type | |
| Formula | C27H39N3O |
| Weight | Average: 421.629 Monoisotopic: 421.309312888 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Nevanimibe
